These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 12649574

  • 1. Increased frequency of islet cell antibodies in unaffected brothers of children with type 1 diabetes.
    Eskola V, Vähäsalo P, Akerblom HK, Knip M, Finnish ENDIT Study Group.
    Horm Res; 2003; 59(4):195-200. PubMed ID: 12649574
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Islet cell antibodies are less predictive of IDDM among unaffected children in the general population than in sibs of children with diabetes. The Childhood Diabetes in Finland Study Group.
    Knip M, Karjalainen J, Akerblom HK.
    Diabetes Care; 1998 Oct; 21(10):1670-3. PubMed ID: 9773728
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The Giessen-Bad Oeynhausen family study: improved prediction of type I diabetes in a low incidence population of relatives using combinations of islet autoantibodies in a dual step model.
    Jaeger C, Hatziagelaki E, Stroedter A, Becker F, Scherer S, Petzoldt R, Federlin K, Bretzel RG.
    Exp Clin Endocrinol Diabetes; 1999 Oct; 107(8):496-505. PubMed ID: 10612480
    [Abstract] [Full Text] [Related]

  • 6. Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes.
    Bonifacio E, Bingley PJ, Shattock M, Dean BM, Dunger D, Gale EA, Bottazzo GF.
    Lancet; 1990 Jan 20; 335(8682):147-9. PubMed ID: 1967440
    [Abstract] [Full Text] [Related]

  • 7. [Evaluation of the importance of antibodies against islet cells (ICA) and Glutamate Decarboxylase(anti-GAD) for determining prognosis of diabetes type 1 in the Polish population--5 year observation].
    Kretowski A, Szelachowska M, Kinalska I.
    Pol Arch Med Wewn; 1999 Apr 20; 101(4):323-7. PubMed ID: 10740410
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Islet cell-specific autoantibodies in children with insulin-dependent diabetes mellitus and their siblings at clinical manifestation of the disease. Childhood Diabetes in Finland Study Group.
    Vähäsalo P, Knip M, Karjalainen J, Tuomilehto-Wolf E, Lounamaa R, Akerblom HK.
    Eur J Endocrinol; 1996 Dec 20; 135(6):689-95. PubMed ID: 9025714
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
    Yamamoto AM, Deschamps I, Garchon HJ, Roussely H, Moreau N, Beaurain G, Robert JJ, Bach JF.
    J Autoimmun; 1998 Dec 20; 11(6):643-50. PubMed ID: 9878086
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Influence of age on the associations among insulin autoantibodies, islet cell antibodies, and HLA DAQ1*0301-DQB1*0302 in siblings of patients with type 1 (insulin-dependent) diabetes mellitus. Belgian Diabetes Registry.
    Gorus FK, Vandewalle CL, Dorchy H, Van Crombrugge P, Schuit FC, Pipeleers DG.
    J Clin Endocrinol Metab; 1994 May 20; 78(5):1172-8. PubMed ID: 8175975
    [Abstract] [Full Text] [Related]

  • 16. Delay of type I diabetes in high risk, first degree relatives by parenteral antigen administration: the Schwabing Insulin Prophylaxis Pilot Trial.
    Füchtenbusch M, Rabl W, Grassl B, Bachmann W, Standl E, Ziegler AG.
    Diabetologia; 1998 May 20; 41(5):536-41. PubMed ID: 9628270
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives.
    Bingley PJ, Christie MR, Bonifacio E, Bonfanti R, Shattock M, Fonte MT, Bottazzo GF, Gale EA.
    Diabetes; 1994 Nov 20; 43(11):1304-10. PubMed ID: 7926304
    [Abstract] [Full Text] [Related]

  • 19. Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk.
    Bingley PJ, Gale EA, European Nicotinamide Diabetes Intervention Trial (ENDIT) Group.
    Diabetologia; 2006 May 20; 49(5):881-90. PubMed ID: 16514546
    [Abstract] [Full Text] [Related]

  • 20. Disease-associated autoantibodies as surrogate markers of type 1 diabetes in young children at increased genetic risk. Childhood Diabetes in Finland Study Group.
    Kimpimäki T, Kulmala P, Savola K, Vähäsalo P, Reijonen H, Ilonen J, Akerblom HK, Knip M.
    J Clin Endocrinol Metab; 2000 Mar 20; 85(3):1126-32. PubMed ID: 10720050
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.